BioCentury
ARTICLE | Company News

Medarex and Biosite in antibody deal

June 1, 2000 7:00 AM UTC

The companies will combine MEDX's HuMAb-Mouse technology with BSTE's Omniclonal phage display technology to produce large numbers of high-affinity, human antibodies for use in validating genomic targe...